Definitive Contract 75F40123C00200
Award Date 9/22/23
Potential Completion Date 9/29/26
Potential Value $4.7M
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Cambridge, MA 02139, USA
Solicitation Procedures
Two Step
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a $4,999,325.00 federal contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to conduct research on controlled protein capture via continuous crystallization and precipitation for monoclonal antibody manufacturing. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science and does not have a set-aside designation. The contract involves research and development activities to advance...
- This is a $5,000,001.00 definitive contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for "APPLICATION OF SMART DATA ANALYTICS FOR BIOMANUFACTURING." The contract has no set-aside designation and is a cost-type contract without fee. The contract was awarded under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which solicits research and development proposals across various regulatory science areas to...
- This federal contract award, valued at $6,038,686.00, was issued by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) to address the ongoing growth in continuous manufacturing within cell lines. The award is part of the FDA's Broad Agency Announcement (BAA) program, which funds extramural research and development to support regulatory science and innovation. The BAA solicitation did not have a set-aside designation. Through this contract, MIT will...
- This federal contract, awarded by the Food and Drug Administration (FDA), provides $2,565,626.00 to the Massachusetts Institute of Technology (MIT) to conduct research and development on "Technologies to Enable Continuous Production of RAAV from SF9/Baculovirus Culture". The contract has no set-aside designation. The work is being performed under the FDA's Broad Agency Announcement for Advanced Regulatory Science, which seeks proposals across eight areas of regulatory science to...
- This is a Definitive Contract awarded by the Food and Drug Administration (FDA) to the Massachusetts Institute of Technology (MIT) for the development of an integrated cGMP facility for mRNA manufacturing. The contract is valued at $82,182,000.00 and has a completion date of September 28, 2026. It is a Firm Fixed Price contract with no set-aside designation. MIT has subcontracted with The Pennsylvania State University and Rensselaer Polytechnic Institute to perform research related to mRNA...
- This federal contract award is for BIOMEDICAL (APPLIED/EXPLORATORY) research and development work, with a ceiling value of $621,724.00. The contract was awarded by the U.S. government to the Massachusetts Institute of Technology (MIT) on April 1, 2009, with a planned completion date of December 31, 2009. The contract is part of the GENOMIC SEQUENCING CENTERS FOR INFECTIOUS DISEASES major program and is a definitive contract with a cost-no-fee pricing type. The work is being performed in...
- The U.S. Food and Drug Administration (FDA) awarded a $1,845,473.00 cost-plus-fixed-fee delivery order contract to The Mitre Corporation, a non-profit organization that operates federally funded research and development centers (FFRDCs). This contract is for the "TITLE 21 MODERNIZATION AND AUTOMATION FOR THE FOOD AND DRUG ADMINISTRATION OFFICE OF TALENT SOLUTIONS" project, which aims to modernize and automate systems for the FDA. The contract has an ultimate completion date of...
- This federal contract award to the Massachusetts Institute of Technology (MIT) is a $31,043 grant for research to execute a balanced science program based on guidance from the National Academies of Sciences, Engineering, and Medicine, administration priorities, and direction from Congress. The contract has an ultimate completion date of July 1, 2026 and was awarded on July 2, 2025. MIT, a premier private research university, will participate as a key partner and enabler in the civilian...
- This federal contract award, valued at $11,348,590.00, was issued by the National Institutes of Health (NIH) to the Massachusetts Institute of Technology (MIT) under an Other Transaction Agreement. The contract, titled "ARPA-H ADAPT AURORA: AI-DRIVEN UNDERSTANDING OF RESPONSE OPTIMIZATION AND RESISTANCE ASSESSMENT," is focused on advanced research and development in artificial intelligence and related technologies. The award does not have a set-aside designation, indicating MIT's broad...
- This federal contract award, valued at $4,835,002, was made by the Food and Drug Administration (FDA) to The Mitre Corporation, a not-for-profit organization that operates federally funded research and development centers. The contract is for system engineering and acquisitions support for the FDA's Office of Acquisitions and Grants Services (OAGS). This is a cost-plus-fixed-fee delivery order contract with a period of performance ending on September 29, 2017. The contract was not set aside...